Stock Taper 
ADAR1 CAPITAL MANAGEMENT, LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Editas Medicine, Inc. | EDIT | 8.89M | $28.8M |
 Roivant Sciences Ltd. | ROIV | 3.16M | $111.73M |
 Vir Biotechnology, Inc. | VIR | 2.46M | $25.03M |
 Immunovant, Inc. | IMVT | 2.33M | $89.8M |
 Inovio Pharmaceuticals, Inc. | INO | 2.14M | $2.36M |
 Prime Medicine, Inc. | PRME | 2M | $7.37M |
 Abivax S.A. | ABVX | 1.8M | $240.49M |
 Prothena Corporation plc | PRTA | 1.55M | $15.22M |
 Enanta Pharmaceuticals, Inc. | ENTA | 1.34M | $19.6M |
 Agios Pharmaceuticals, Inc. | AGIO | 1.29M | $47.8M |
 Arbutus Biopharma Corp | ABUS | 1.27M | $6.09M |
 Crinetics Pharmaceuticals, Inc. | CRNX | 1.22M | $45.73M |
 Denali Therapeutics Inc. | DNLI | 1.03M | $26.47M |
 Protagonist Therapeutics, Inc. | PTGX | 960.86K | $117.78M |
 Septerna Inc | SEPN | 940.75K | $31.51M |
 Protara Therapeutics, Inc. | TARA | 940.51K | $3.59M |
 Atai Beckley Inc. | ATAI | 913.24K | $4.81M |
 Lexicon Pharmaceuticals, Inc. | LXRX | 750K | $1.8M |
 Sarepta Therapeutics, Inc. | SRPT | 730.65K | $13.13M |
 Replimune Group, Inc. | REPL | 655.78K | $7.26M |